Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)

NCT03105596 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

B-cell Non-Hodgkin's Lymphoma

Interventions

DRUG: Chidamide plus DICE Regimen

Sponsor

Peking University